Atlas Oncology Partners partners with community oncology practices to deliver coordinated, patient-centered cancer care by embedding interdisciplinary teams of providers, nurses, patient navigators, and social workers directly into the practices. Its model combines patient navigation, psychosocial and supportive services, proactive care coordination, and expanded in-person and virtual clinical access. Uniquely, Atlas assumes full medical cost risk from payors and aligns incentives across patients, oncologists, and insurers to lower avoidable costs while enhancing outcomes. Founded and incubated by Rubicon Founders, the company seeks to solve fragmentation in cancer care and ease the financial burden on patients. With its platform, Atlas invests in partner operations to enable high-quality, value-based oncology at scale. The recent $28 million Series A financing strengthens the company’s balance sheet and will fund geographic expansion and further development of its clinical and operational infrastructure.

Total raised

$28M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2026